RecruitingNCT05165095
Clinical Assessment of Essential Remote Monitoring Functions in Pacemakers
Sponsor
MicroPort CRM
Enrollment
206 participants
Start Date
Mar 25, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of the clinical investigation is to document the safety and the performances of the remote monitoring functions of the ALIZEA, BOREA and CELEA pacemakers, i.e. the RAAT, the RVAT and the remote alerts.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Patient implanted according to the most recent guidelines from the ESC, for 20 days or less (de novo implantation, device upgrade to dual chamber or device replacement)
- Patient implanted with an ALIZEA, BOREA or CELEA dual chamber pacemaker from MicroPort CRM
- Patient implanted with any active or passive CE marked bipolar RA lead, and any active or passive CE marked bipolar RV lead
- Patient's pacemaker with the remote monitoring functions (i.e. the RAAT, the RVAT and the remote alerts) accepted by the patient and planned to be activated
- Patient reviewed, signed and dated the ICF
Exclusion Criteria8
- Patient with an elevated RV pacing threshold (strictly above 2.0 V for a pulse width of 0.5 ms or below)
- Patient with permanent AF
- Patient already enrolled in another clinical investigation that could confound the results of this clinical investigation (e.g., clinical investigations involving intra-cardiac device)
- Patient implanted despite a contraindication for cardiac pacing system implantation (i.e. patient implanted with a defibrillator, patient contraindicated for a single dose of 310 μg of dexamethasone sodium phosphate, patient implanted with a tricuspid replacement heart valve or with a significant tricuspid valve disease that may lead to future replacement heart valve surgery)
- Minor age patient (i.e. under 18 years of age)
- Incapacitated patient, under guardianship, kept in detention, refusing to cooperate or not able to understand the purpose of this clinical investigation
- Patient unavailable for the follow-up visits scheduled
- Non-menopausal women
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEPacemaker implantation
De novo implantation, device upgrade to dual chamber or device replacement
Locations(19)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05165095
Related Trials
Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker
NCT075631531 location
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
NCT0720985213 locations
Left Bundle Branch Area Pacing (LBBAP) PMCF Study
NCT0721739213 locations
Dexmedetomidine and Propofol for Sedation in Cataract Surgery.
NCT075561331 location
Remote ECG Monitoring Post TAVI
NCT075218004 locations